top of page
REPOSE
REPOTRECTINIB IN ROS1-POSITIVE NON-SMALL CELL LUNG CANCER PATIENTS WITH ACTIVE BRAIN METASTASIS
A PHASE II STUDY ASSESSING SAFETY AND EFFICACY OF REPOTRECTINIB IN ROS1-POSITIVE NON-SMALL CELL LUNG CANCER PATIENTS WITH ACTIVE BRAIN METASTASIS (REPOSE STUDY)
REPOSE AT CLINICALTRIALS.GOV
SCIENTIFIC IMPACT
WCLC 2025 - DOWNLOAD THE POSTER
TRIAL RESUME
CLINICAL TRIAL DETAILS
TUMOR TYPE
PHASE
nsclc BMs
II
20
TBC
Spain, Germany,
Austria
Recruitment
N
SITES
COUNTRY
STATUS
bottom of page